The Discounted Cash Flow (DCF) valuation of Krystal Biotech Inc (KRYS) is 55.57 USD. With the latest stock price at 139.74 USD, the upside of Krystal Biotech Inc based on DCF is -60.2%.
Based on the latest price of 139.74 USD and our DCF valuation, Krystal Biotech Inc (KRYS) is a sell. selling KRYS stocks now will result in a potential gain of 60.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.0% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 34.60 - 404.67 | 55.57 |
| Upside | -75.2% - 189.6% | -60.2% |